Brochure
29 Nov 2023
Lyrus Life Science Brochure
PDF 1.0 MB
Introduction:The Lyrus Life Science brochure provides a comprehensive overview of our company's capabilities, management profile, research and development strengths, and production facilities. It serves as a valuable resource to gain insights into our operations and the therapies we specialize in. At Lyrus Life Science, we are committed to developing innovative products using non-infringing technologies, revolutionizing the healthcare industry.
Content provided by our supplier
Lyrus Life Sciences
-
IN -
2019On CPHI since
-
4Certificates
-
250 - 499Employees
Company types
Primary activities
Other Content from Lyrus Life Sciences (1)
-
News Lyrus Receives US FDA approval for Critical UTI treatment in the US
Lyrus has received US FDA approval for our Abbreviated New Drug Application (ANDA) for 'Methenamine Hippurate Tablets USP, 1 gram', an AB-rated, substitutable generic version of Hiprex®.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance